These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 11423935
21. Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus. Lenhoff RJ, Luscombe CA, Summers J. Virology; 1998 Nov 10; 251(1):85-95. PubMed ID: 9813205 [Abstract] [Full Text] [Related]
26. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication? Lavigne C, Yelle J, Sauve G, Thierry AR. AAPS PharmSci; 2002 May 10; 4(2):E9. PubMed ID: 12102618 [Abstract] [Full Text] [Related]
27. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection. Miller DS, Halpern M, Kotlarski I, Jilbert AR. Virology; 2006 May 10; 348(2):297-308. PubMed ID: 16469347 [Abstract] [Full Text] [Related]
28. Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo. Zhou Z, Zhang Y, Ding XR, Chen SH, Yang J, Wang XJ, Jia GL, Chen HS, Bo XC, Wang SQ. Antiviral Res; 2007 Apr 10; 74(1):59-64. PubMed ID: 17298850 [Abstract] [Full Text] [Related]
29. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica. Han YQ, Huang ZM, Yang XB, Liu HZ, Wu GX. J Ethnopharmacol; 2008 Jun 19; 118(1):148-53. PubMed ID: 18495393 [Abstract] [Full Text] [Related]
30. In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L. Li J, Huang H, Feng M, Zhou W, Shi X, Zhou P. Antiviral Res; 2008 Aug 19; 79(2):114-20. PubMed ID: 18423640 [Abstract] [Full Text] [Related]
31. Inhibition of tumor necrosis factor alpha secretion and prevention of liver injury in ethanol-fed rats by antisense oligonucleotides. Ponnappa BC, Israel Y, Aini M, Zhou F, Russ R, Cao QN, Hu Y, Rubin R. Biochem Pharmacol; 2005 Feb 15; 69(4):569-77. PubMed ID: 15670576 [Abstract] [Full Text] [Related]
32. Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo. Biessen EA, Vietsch H, Rump ET, Fluiter K, Kuiper J, Bijsterbosch MK, van Berkel TJ. Biochem J; 1999 Jun 15; 340 ( Pt 3)(Pt 3):783-92. PubMed ID: 10359665 [Abstract] [Full Text] [Related]
34. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV. Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317 [Abstract] [Full Text] [Related]
36. Sequence-specific inhibition of gene expression in intact human skin by epicutaneous application of chimeric antisense oligodeoxynucleotides. Wingens M, Pfundt R, van Vlijmen-Willems IM, van Hooijdonk CA, van Erp PE, Schalkwijk J. Lab Invest; 1999 Nov 01; 79(11):1415-24. PubMed ID: 10576212 [Abstract] [Full Text] [Related]
37. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts. Ramachandran C, Wellham LL. Anticancer Res; 2003 Nov 01; 23(3B):2681-90. PubMed ID: 12894558 [Abstract] [Full Text] [Related]
39. Synthesis and characterization of dexamethasone-conjugated linear polyethylenimine as a gene carrier. Kim H, Bae YM, Kim HA, Hyun H, Yu GS, Choi JS, Lee M. J Cell Biochem; 2010 Jun 01; 110(3):743-51. PubMed ID: 20512934 [Abstract] [Full Text] [Related]
40. Inhibition of the hepatitis B virus replication in vitro by an oligodeoxynucleotide containing cytidine-guanosine motifs. Li N, Fan XG, Chen ZH, Zhu C, Liu HB, Huang Y. Immunol Lett; 2006 Jan 15; 102(1):60-6. PubMed ID: 16105691 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]